MedPath

Telomeres Parameters in Celiac Disease

Not Applicable
Conditions
Celiac Disease
Interventions
Procedure: take blood samples
Registration Number
NCT02126033
Lead Sponsor
Meir Medical Center
Brief Summary

Celiac disease is an autoimmune process that causes destructive changes in the epithel of the small bowel and it is also a pre-malignant state (e.g lymphoma). The aim of the study is to examine telomere length and other parameters of genetic instability from peripheral blood lymphocytes of patients with celiac disease compared with healthy controls.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
40
Inclusion Criteria
  • patients with celiac disease
Read More
Exclusion Criteria
  • known malignancy
  • cannot sign informed consent
  • under age 18
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
celiac diseasetake blood samples-
Primary Outcome Measures
NameTimeMethod
telomere lengthat entry, after 6 months of gluten-free diet
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath